• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Low oxygen and weight status trial seeking participants at Pennington Biomedical

by
August 15, 2024
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Can reduced oxygen in the air lead to weight loss? That is what Pennington Biomedical researcher Dr. Claire Berryman is exploring in the “Low Oxygen and Weight Status,” or LOWS, study, which is currently recruiting participants. The study is open to adults between the ages of 22 and 65, and it lasts up to four months.

Hypoxic Tent

Credit: PBRC

Can reduced oxygen in the air lead to weight loss? That is what Pennington Biomedical researcher Dr. Claire Berryman is exploring in the “Low Oxygen and Weight Status,” or LOWS, study, which is currently recruiting participants. The study is open to adults between the ages of 22 and 65, and it lasts up to four months.

The study starts with a two-week weight maintenance phase with all foods provided to study participants. Then, for eight weeks, participants will receive a weight loss diet and be asked to sleep in a tent placed over their beds. Participants will be randomly assigned to two groups – a group whose tents have normal oxygen levels or a group whose tents have a reduced oxygen level, similar to high altitude areas like Aspen, Colorado at 8,500 feet above sea level. Throughout the study, participants’ body weights and metabolic changes will be carefully monitored to understand how varying oxygen levels impact weight loss.

“Both groups can expect to lose weight, since everyone receives a calorie-restricted diet for eight weeks,” said Dr. Berryman, an associate professor of clinical sciences who runs the Nutritional Physiology Lab at Pennington Biomedical. “The study provides participants the unique opportunity to sleep with a specialized tent over their bed, which are the same types of tents used by elite athletes to simulate high-altitude conditions for performance benefits. We are exploring if lower oxygen levels in the air lead to increases in energy expenditure, decreases in appetite, greater body weight loss, and better insulin sensitivity.”

The study originated from Dr. Berryman’s previous research in which she investigated the health and performance of soldiers during training missions at high altitudes. Data from this research indicated that weight loss in this otherwise healthy population was greater at higher altitudes than it was under similar conditions at sea level. Such effects have the potential to negatively impact soldiers’ readiness and performance but may benefit those with excess body weight.

“While diet and exercise take center stage in the field of weight loss research, Dr. Berryman’s study explores additional factors that may be instrumental in the body’s calorie-burning potential,” said Dr. John Kirwan, Executive Director of Pennington Biomedical. “Pennington Biomedical is proud to have recruited some of the leading minds in biomedical research to our facility. Dr. Berryman’s inventive study is rooted in her prior experience and her commitment to discover new pathways to metabolic health.”

Dr. Berryman’s current study at Pennington Biomedical explores low oxygen as a potential tool for weight loss in adults with obesity. Participants will be compensated up to $2,000 for taking part in the trial. To learn more about the study and to sign up, visit www.pbrc.edu/lows.

About the Pennington Biomedical Research Center
The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. The Center conducts basic, clinical, and population research, and is a campus of the LSU System. The research enterprise at Pennington Biomedical includes over 530 employees within a network of 44 clinics and research laboratories, and 13 highly specialized core service facilities. Its scientists and physician/scientists are supported by research trainees, lab technicians, nurses, dietitians, and other support personnel. Pennington Biomedical is a state-of-the-art research facility on a 222-acre campus in Baton Rouge. For more information, see www.pbrc.edu.



Share12Tweet8Share2ShareShareShare2

Related Posts

Wearable Devices Improve Parkinson’s Medication Adjustments: Trial

Wearable Devices Improve Parkinson’s Medication Adjustments: Trial

August 21, 2025
How Cancer Affects the Accuracy of Forensic DNA Methylation Age Estimation

How Cancer Affects the Accuracy of Forensic DNA Methylation Age Estimation

August 21, 2025

STING Triggers ZBP1 Necroptosis Without TNFR1

August 21, 2025

Toxoplasma, IL-1 Cause DNA Damage, Cognitive Decline

August 21, 2025

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Wearable Devices Improve Parkinson’s Medication Adjustments: Trial

Beijing Tiantan Hospital Researchers Develop Innovative One-Stage Hybrid Surgery for Brain and Spine Tumors

On-Chip All-Dielectric Metasurface Enables Creation of Topological Exceptional Points

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.